Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/24/2007EP1847268A1 Multiple unit oral sustained release preparation and process for production of the same
10/24/2007EP1847267A2 Method of photodynamic diagnosis for vascular diseases
10/24/2007EP1847266A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
10/24/2007EP1847265A1 The use of flavonol and flavonol glycosides for stimulating growth of renal tubular epithelial cells to secrete the kidney secreting bone growth factor
10/24/2007EP1847264A1 Patch
10/24/2007EP1847263A2 Inhibitors against the production and release of inflammatory cytokines
10/24/2007EP1847260A2 Solid dispersion preparation
10/24/2007EP1847257A2 Solid preparation comprising enteric solid dispersion
10/24/2007EP1847256A1 Antibacterial compositions for the treatment of infections of the upper and lower airways
10/24/2007EP1847247A1 Compositions comprising a hydroxylated diphenyl-methane derivative
10/24/2007EP1847244A1 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
10/24/2007EP1847182A2 Foodstuffs or dietary supplements containing flavonoid derivates
10/24/2007EP1846563A2 Production of polyunsaturated fatty acids using novel cell treatment method
10/24/2007EP1846557A2 Rnai-mediated inhibition of ocular targets
10/24/2007EP1846550A2 Use of the mcm8 gene for the preparation of a pharmaceutical composition
10/24/2007EP1846454A2 Human monoclonal antibodies to fc gamma receptor ii (cd32)
10/24/2007EP1846434A1 NANDROLONE 17ß-CARBONATES
10/24/2007EP1846430A1 New macrolides
10/24/2007EP1846428A1 Anti-inflammatory conjugates of macrolides and coumarins
10/24/2007EP1846424A1 Proteasome inhibitors and methods of using the same
10/24/2007EP1846419A2 Alkyloxy substituted thiazoloquinolines and thiazolonaphthyridines
10/24/2007EP1846418A2 Antibacterial agents
10/24/2007EP1846417A1 Antibacterial agents
10/24/2007EP1846416A2 Antibacterial agents
10/24/2007EP1846415A1 Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
10/24/2007EP1846414A1 Tetracyclic monoamine reuptake inhibitors for treatment of cns diseases and disorders
10/24/2007EP1846413A2 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
10/24/2007EP1846411A2 Antibacterial agents
10/24/2007EP1846410A2 Dihydroquinazolinones as 5ht modulators
10/24/2007EP1846409A1 Octahydropyrrolo[3,4-c]pyrrole derivatives
10/24/2007EP1846408A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors
10/24/2007EP1846407A1 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitors of renin for the treatment of hypertension.
10/24/2007EP1846406A1 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
10/24/2007EP1846405A2 Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
10/24/2007EP1846404A1 Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
10/24/2007EP1846403A1 Azabicyclo derivatives as anti-inflammatory agents
10/24/2007EP1846402A1 3-amino-pyrazolo[3,4b]pyridines used as inhibitors of protein tyrosine kinases for treating angiogenic, hyperproliferative or neurodegenerative diseases
10/24/2007EP1846401A1 New 4-aminoquinoline derivatives as antimalarials
10/24/2007EP1846400A2 Tricyclic delta-opioid modulators
10/24/2007EP1846399A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
10/24/2007EP1846397A1 Novel heterocyclic benzoy[c]chromene derivatives useful as modulators of the estrogen receptors
10/24/2007EP1846396A2 Substituted 4-(indol-3-yl)quinazolines and their use
10/24/2007EP1846395A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
10/24/2007EP1846394A1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/24/2007EP1846393A2 4-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
10/24/2007EP1846391A2 Raf inhibitor compounds and methods
10/24/2007EP1846390A1 Novel 6-pyridylphenanthridines
10/24/2007EP1846389A1 Imidazole derivatives
10/24/2007EP1846388A1 Thiophene compounds for inflammation and immune-related uses
10/24/2007EP1846387A2 Bis-(coumarin) compounds with anti-inflammatory activity
10/24/2007EP1846386A2 Novel coumarin derivatives as ion channel openers
10/24/2007EP1846384A1 Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine
10/24/2007EP1846383A2 Rigidified compounds for modulating heparanase activity
10/24/2007EP1846380A1 Cardiovascular compounds comprising heterocyclic nitric oxide donor group compositions and methods of use
10/24/2007EP1846379A1 Antidiabetic bicyclic compounds
10/24/2007EP1846378A2 Cationic lipids for the transfection of nucleic acids
10/24/2007EP1846377A2 Form iv crystalline celecoxib
10/24/2007EP1846376A2 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide
10/24/2007EP1846375A1 2-amino-1-phenylethylcarboxamide derivatives
10/24/2007EP1846374A1 Cinnamate salts of a beta-2 adrenergic agonist
10/24/2007EP1846373A2 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
10/24/2007EP1846370A2 2-METHYLENE-19-NOR-1&agr;-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES
10/24/2007EP1846369A2 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
10/24/2007EP1846366A1 Norvaline derivative and method for preparation thereof
10/24/2007EP1846365A1 Diamine calcium channel blockers
10/24/2007EP1846364A1 New potent and selective ligands of cannabinoid receptors
10/24/2007EP1846363A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1846362A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1846360A1 A sulphonic acid salt of sibutramine
10/24/2007EP1846359A1 Inorganic acid salts of sibutramine
10/24/2007EP1846355A1 Fatty acid-benzenediol derivatives and methods of making and using thereof
10/24/2007EP1846354A2 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
10/24/2007EP1846105A2 Use of adrenergic alpha2b antagonists for the treatment of vasomotor symptoms
10/24/2007EP1846058A1 Device method, and use for treatment of neuropathy involving nitric oxide
10/24/2007EP1846057A1 Device for treatment of disorders in the oral cavity with nitric oxide, and manufacturing process for the same
10/24/2007EP1846037A1 Methods of treating various conditions by administration of sustained release l-arginine
10/24/2007EP1846036A1 Reducing drug dependence or addiction
10/24/2007EP1846033A2 Blockade of elr+cxc chemokines as a treatment for inflammatory and autoimmune disease
10/24/2007EP1846026A2 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
10/24/2007EP1846012A1 Stabilised plant extract and its therapeutic use
10/24/2007EP1846009A2 Improved device for application of medicaments, manufacturing method therefor, and method of treatment
10/24/2007EP1846008A1 Method for the mitigation of symptoms of contact lens related dry eye
10/24/2007EP1846007A1 Skin-protective polymer for use in teat care compositions
10/24/2007EP1846006A2 Beta-cyclodextrin derivatives as antibacterial agents
10/24/2007EP1846005A2 Kits and improved compositions for treating lower urinary tract
10/24/2007EP1846004A1 New uses of dinucleotide polyphosphate derivatives
10/24/2007EP1846003A1 9a-carbamoyl and thiocarbamoyl azalides with anti-inflammatory activity
10/24/2007EP1846002A1 Method for blood glucose control in a mammal by n-acylated glucosamines
10/24/2007EP1846000A1 Pharmaceutical compositions containing bisphosphonate for improving oral absorption
10/24/2007EP1845999A1 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases
10/24/2007EP1845998A2 A method for treating neurologic diseases
10/24/2007EP1845997A2 Apoptosis-inducing antineoplastic silver (i) coordination complexes
10/24/2007EP1845996A1 Compositions and methods relating to novel compounds and targets thereof
10/24/2007EP1845995A1 Antibacterial agents
10/24/2007EP1845994A1 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases
10/24/2007EP1845993A2 Novel adenosine a3 receptor modulators
10/24/2007EP1845992A1 Use of tyrosine kinase inhibitors for the treatment of chronic rhinosinusitis
10/24/2007EP1845991A2 Substituted 5-phenyl pyrimidines i in therapy
10/24/2007EP1845990A2 Treatment of metastasized tumors
10/24/2007EP1845989A1 Use of methylnaltrexone and related compounds to treat post-operative gastrointestinal dysfunction
1 ... 3533 3534 3535 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 3551 3552 3553 ... 7860